Form 8-K · Current report
Avery Dennison 8-K, filed Aug 19, 2026
- Filed
- CIK
- 0000008818
- Accession no.
- 0000008818-26-000141
Summary
Avery Dennison's board unanimously elected William Wagner as independent Board Chair effective September 1, 2026, for the remainder of the term ending at the 2027 annual meeting. Mitchell Butier continues as non-executive Chairman through August 31, 2026, and Patrick Siewert will cease as Lead Independent Director and take over as Governance Committee Chair.
Key points
- William Wagner has served as an independent Avery Dennison director since October 2022 and chairs its Governance and Cybersecurity Committees.
- Mitchell Butier will remain a non-independent board member for the remainder of the term after stepping down as non-executive Chairman.
- The board determined a Lead Independent Director is no longer required under its corporate governance guidelines because Wagner is independent under NYSE listing standards.
- Patrick Siewert will succeed Wagner as Governance Committee Chair effective September 1, 2026.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 8.01Other Events
From the filing
Item 8.01 Other Events. On August 18, 2026, consistent with its thoughtful long-term Board leadership succession planning process, the Board of Directors (the “Board”) of Avery Dennison Corporation, a Delaware corporation (the “Company”), unanimously elected William Wagner as independent Board Chair, effective September 1, 2026, to serve in such capacity for the remainder of the one-year term ending at the 2027 Annual Meeting of Stockholders (the “Annual Meeting”). Mitchell Butier will continue to serve as non-executive Chairman through August 31, 2026 and as a non-independent member of the Board for the remainder of the one-year term ending at the Annual Meeting. Mr. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.